Special Reports
The State of AI-Enabled Drug Discovery: Q1-2025 Report
Discover the impact of artificial intelligence in the pharmaceutical industry through our Q1-2025 report:
-
Comprehensive Analysis: Examines the challenges and ethical issues associated with AI in drug discovery.
-
Technological Insights: Details the AI techniques used and the major players influencing this field.
-
Future Outlook: Discusses key trends and future directions, highlighting AI's role in enhancing drug development efficiency and patient care.
-
Expert Perspectives: Offers findings validated by industry experts, providing a reliable source of information for stakeholders.
Access the full report for a thorough exploration of AI's evolving role in transforming drug discovery and healthcare.
Get an executive-level analysis of the key trends from the 2025 JP Morgan Healthcare Conference that will shape the biopharma and medtech landscape. This comprehensive briefing covers:
-
M&A activity and the $1.3 trillion in "firepower" held by top 25 biopharma companies
-
Breakthrough developments in GLP-1 therapeutics, oncology, RNA therapeutics, and gene editing
-
AI and digital health transformation driving $25B+ in funding
-
Venture capital trends and investment priorities
-
Strategic implications of the new Trump administration
Based on insights from 8,000 industry leaders and 500 company presentations, this report provides actionable recommendations for healthcare executives to capitalize on the evolving market dynamics.
